{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:05:50Z","timestamp":1789981550660,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,21]]},"DOI":"10.7759\/cureus.116625","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:27:51Z","timestamp":1789979271000},"source":"Crossref","is-referenced-by-count":0,"title":["Literature Review of Occult Hepatitis B Infection and Hepatitis B Core Antibody-Positive Blood Donors"],"prefix":"10.7759","author":[{"given":"Aphisit","family":"Thongthaisin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sauleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01426.x","article-title":"Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century","volume":"100","author":"Dwyre DM","year":"2011","unstructured":"Dwyre DM, Fernando LP, Holland PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang. 2011, 100:92-8. 10.1111\/j.1423-0410.2010.01426.x","journal-title":"Vox Sang"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-833996","article-title":"Prevention of transfusion-transmitted infections","volume":"133","author":"Busch MP","year":"2019","unstructured":"Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019, 133:1854-64. 10.1182\/blood-2018-11-833996","journal-title":"Blood"},{"key":"ref3","article-title":"Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations. World Health Organization, Geneva; 2009."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.126682","article-title":"Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus","volume":"8","author":"Shyamala V","year":"2014","unstructured":"Shyamala V. Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. Asian J Transfus Sci. 2014, 8:13-8. 10.4103\/0973-6247.126682","journal-title":"Asian J Transfus Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00258-10","article-title":"False-positive rate of a \"fourth-generation\" HIV antigen\/antibody combination assay in an area of low HIV prevalence","volume":"17","author":"Kim S","year":"2010","unstructured":"Kim S, Lee JH, Choi JY, Kim JM, Kim HS. False-positive rate of a \"fourth-generation\" HIV antigen\/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol. 2010, 17:1642-4. 10.1128\/CVI.00258-10","journal-title":"Clin Vaccine Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12056","article-title":"Donor selection for blood safety: is it still necessary?","volume":"9","author":"Lin CK","year":"2014","unstructured":"Lin CK, Leung JNS, So BKL, Lee CK. Donor selection for blood safety: is it still necessary?. ISBT Sci Series. 2014, 9:26-9. 10.1111\/voxs.12056","journal-title":"ISBT Sci Series"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2009.01224.x","article-title":"Pathogen-reduction methods: advantages and limits","volume":"4","author":"Klein HG","year":"2009","unstructured":"Klein HG, Bryant BJ. Pathogen-reduction methods: advantages and limits. ISBT Sci Ser. 2009, 4:154-60. 10.1111\/j.1751-2824.2009.01224.x","journal-title":"ISBT Sci Ser"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57584-z","article-title":"COVID-19 impact on blood donor characteristics and seroprevalence of transfusion-transmitted infections in southern Thailand between 2018 and 2022","volume":"14","author":"Burananayok S","year":"2024","unstructured":"Burananayok S, Nachatri W, Choothanorm P, et al.. COVID-19 impact on blood donor characteristics and seroprevalence of transfusion-transmitted infections in southern Thailand between 2018 and 2022. Sci Rep. 2024, 14:7920. 10.1038\/s41598-024-57584-z","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87474-7","article-title":"Rising prevalence of HIV infection and associated risk factors among young Thai Men in 2018","volume":"11","author":"Jose JE","year":"2021","unstructured":"Jose JE, Sakboonyarat B, Mungthin M, Nelson KE, Rangsin R. Rising prevalence of HIV infection and associated risk factors among young Thai Men in 2018. Sci Rep. 2021, 11:7796. 10.1038\/s41598-021-87474-7","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2023.103795","article-title":"Blood banking in Thailand 2023","volume":"62","author":"Vipusmith C","year":"2023","unstructured":"Vipusmith C. Blood banking in Thailand 2023. Transfus Apher Sci. 2023, 62:103795. 10.1016\/j.transci.2023.103795","journal-title":"Transfus Apher Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84854-7","article-title":"Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand","volume":"15","author":"Nilyanimit P","year":"2025","unstructured":"Nilyanimit P, Wanlapakorn N, Vichaiwattana P, et al.. Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand. Sci Rep. 2025, 15:1167. 10.1038\/s41598-024-84854-7","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jve.2020.100003","article-title":"Towards the elimination of viral hepatitis in Thailand by the year 2030","volume":"6","author":"Posuwan N","year":"2020","unstructured":"Posuwan N, Wanlapakorn N, Sintusek P, Wasitthankasem R, Poovorawan K, Vongpunsawad S, Poovorawan Y. Towards the elimination of viral hepatitis in Thailand by the year 2030. J Virus Erad. 2020, 6:100003. 10.1016\/j.jve.2020.100003","journal-title":"J Virus Erad"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907013410104","article-title":"Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease","volume":"341","author":"Cacciola I","year":"1999","unstructured":"Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999, 341:22-6. 10.1056\/NEJM199907013410104","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo G","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019, 71:397-408. 10.1016\/j.jhep.2019.03.034","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta C","year":"2022","unstructured":"Saitta C, Pollicino T, Raimondo G. Occult hepatitis B virus infection: an update. Viruses. 2022, 14:1504. 10.3390\/v14071504","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18609","article-title":"Evaluating the cost-effectiveness of low-level HBV DNA screening in occult hepatitis B infection donors: a study from Shandong Blood Center, China","volume":"9","author":"Chen J","year":"2023","unstructured":"Chen J, Ma Z, Wu D, et al.. Evaluating the cost-effectiveness of low-level HBV DNA screening in occult hepatitis B infection donors: a study from Shandong Blood Center, China. Heliyon. 2023, 9:e18609. 10.1016\/j.heliyon.2023.e18609","journal-title":"Heliyon"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti D","year":"2009","unstructured":"Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009, 51:798-809. 10.1016\/j.jhep.2009.05.020","journal-title":"J Hepatol"},{"key":"ref18","unstructured":"Occult Hepatitis B Infection in UK Blood Donors Report. (2021). Accessed. May 1, 2026: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1149249\/Occult_Blood_...."},{"key":"ref19","unstructured":"Eligibility Criteria for Blood Donors. (2024). Accessed. September 4, 2026: https:\/\/thaibloodcentre.redcross.or.th\/en\/donor-eligibility\/."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103095","article-title":"Occult hepatitis B virus infection: risk for a blood supply, but how about individuals' health?","volume":"81","author":"Fu MX","year":"2025","unstructured":"Fu MX, Elsharkawy A, Healy B, et al.. Occult hepatitis B virus infection: risk for a blood supply, but how about individuals' health?. EClinicalMedicine. 2025, 81:103095. 10.1016\/j.eclinm.2025.103095","journal-title":"EClinicalMedicine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.600","article-title":"Occult hepatitis B virus infection and blood transfusion","volume":"7","author":"Seo DH","year":"2015","unstructured":"Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol. 2015, 7:600-6. 10.4254\/wjh.v7.i3.600","journal-title":"World J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15393","article-title":"Optimal titer of anti-HBs in blood components derived from donors with anti-HBc","volume":"59","author":"Hoshi Y","year":"2019","unstructured":"Hoshi Y, Hasegawa T, Yamagishi N, et al.. Optimal titer of anti-HBs in blood components derived from donors with anti-HBc. Transfusion. 2019, 59:2602-11. 10.1111\/trf.15393","journal-title":"Transfusion"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15057","article-title":"Recent and occult hepatitis B virus infections among blood donors in the United States","volume":"59","author":"Ramachandran S","year":"2019","unstructured":"Ramachandran S, Groves JA, Xia GL, et al.. Recent and occult hepatitis B virus infections among blood donors in the United States. Transfusion. 2019, 59:601-11. 10.1111\/trf.15057","journal-title":"Transfusion"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12096","article-title":"Infectivity of blood products from donors with occult hepatitis B virus infection","volume":"53","author":"Allain JP","year":"2013","unstructured":"Allain JP, Mihaljevic I, Gonzalez-Fraile MI, et al.. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion. 2013, 53:1405-15. 10.1111\/trf.12096","journal-title":"Transfusion"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18018","article-title":"International review of blood donation screening for anti-HBc and occult hepatitis B virus infection","volume":"64","author":"Fu MX","year":"2024","unstructured":"Fu MX, Faddy HM, Candotti D, et al.. International review of blood donation screening for anti-HBc and occult hepatitis B virus infection. Transfusion. 2024, 64:2144-56. 10.1111\/trf.18018","journal-title":"Transfusion"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v14i3.9793","article-title":"Prevalence of occult hepatitis B virus infection among the blood donors in Golestan province: cross-sectional study","volume":"14","author":"Bahrami A","year":"2022","unstructured":"Bahrami A, Pourfathollah AA, Parsania M, Mehrabi Habibabadi H, Sharifi Z. Prevalence of occult hepatitis B virus infection among the blood donors in Golestan province: cross-sectional study. Iran J Microbiol. 2022, 14:410-6. 10.18502\/ijm.v14i3.9793","journal-title":"Iran J Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2016.1248171","article-title":"Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India","volume":"110","author":"Keechilot CS","year":"2016","unstructured":"Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health. 2016, 110:287-91. 10.1080\/20477724.2016.1248171","journal-title":"Pathog Glob Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v5.i2.64","article-title":"Occult hepatitis B virus infection among Egyptian blood donors","volume":"5","author":"Said ZN","year":"2013","unstructured":"Said ZN, Sayed MH, Salama II, et al.. Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol. 2013, 5:64-73. 10.4254\/wjh.v5.i2.64","journal-title":"World J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13135","article-title":"Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors","volume":"55","author":"Gou H","year":"2015","unstructured":"Gou H, Pan Y, Ge H, et al.. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors. Transfusion. 2015, 55:2272-81. 10.1111\/trf.13135","journal-title":"Transfusion"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0019-7","article-title":"Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low endemicity for HBV","volume":"53","author":"Kupski C","year":"2008","unstructured":"Kupski C, Tr\u00e4sel FR, Mazzoleni F, Winckler MA, Bender AL, Machado DC, Schmitt VM. Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low endemicity for HBV. Dig Dis Sci. 2008, 53:1370-4. 10.1007\/s10620-007-0019-7","journal-title":"Dig Dis Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.09.018","article-title":"Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing","volume":"32","author":"Weber B","year":"2005","unstructured":"Weber B, M\u00fchlbacher A, Melchior W. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing. J Clin Virol. 2005, 32:67-70. 10.1016\/j.jcv.2004.09.018","journal-title":"J Clin Virol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16420","article-title":"Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing","volume":"61","author":"van de Laar TJ","year":"2021","unstructured":"van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. Transfusion. 2021, 61:2116-24. 10.1111\/trf.16420","journal-title":"Transfusion"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2450\/2012.0160-12","article-title":"Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection","volume":"11","author":"Roman\u00f2 L","year":"2013","unstructured":"Roman\u00f2 L, Velati C, Cambi\u00e8 G, Fomiatti L, Galli C, Zanetti AR. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013, 11:281-8. 10.2450\/2012.0160-12","journal-title":"Blood Transfus"},{"key":"ref34","article-title":"Hepatitis B and hepatitis C virus in Thai blood donors","volume":"42","author":"Chimparlee N","year":"2011","unstructured":"Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health. 2011, 42:609-15.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03023.x","article-title":"Occult hepatitis B virus infection in Thai blood donors","volume":"51","author":"Louisirirotchanakul S","year":"2011","unstructured":"Louisirirotchanakul S, Oota S, Khuponsarb K, et al.. Occult hepatitis B virus infection in Thai blood donors. Transfusion. 2011, 51:1532-40. 10.1111\/j.1537-2995.2010.03023.x","journal-title":"Transfusion"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/533896-literature-review-of-occult-hepatitis-b-infection-and-hepatitis-b-core-antibody-positive-blood-donors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:27:55Z","timestamp":1789979275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/533896-literature-review-of-occult-hepatitis-b-infection-and-hepatitis-b-core-antibody-positive-blood-donors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.116625","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}